title: Is bevacizumab effective for reducing epistaxis in hereditary hemorrhagic telangiectasia?
authors: Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Dalhousie Medicine New Brunswick, Saint John, New Brunswick, Canada.
authors: Christopher J
authors: CJ
authors: Chin
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D004844:Epistaxis / Q000517:prevention & control*; D006801:Humans; D017410:Practice Guidelines as Topic; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab